Hong-Can Ren

6PUBLICATIONS
0CO-AUTHORS
Instrumental methods (excl. immunological and bioassay methods)Pharmaceutical delivery technologiesEpigenetics (incl. genome methylation and epigenomics)Wastewater treatment processesBiomolecular modelling and design
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Jul 14, 2026
Development and Validation of a Sensitive UHPLC-MS/MS Analytical Method for Fulzerasib in Rat Plasma and its Application to Pharmacokinetics Studies.

|Dec 18, 2025
Assessing DDI risks in drug discovery and development: approaches, challenges, and trends.

Hong-Can Ren, Chunyong He, Hong Wan

|Dec 11, 2023
Development and validation of a sensitive UPLC-MS/MS analytical method for GFH009 in rat plasma and its application to toxicokinetics studies.

Qiang Liu, Jin-Zhu Zhao, Fu-Sheng Zhou

|Sep 25, 2023
Enhancing drug-drug Interaction Prediction by Integrating Physiologically-Based Pharmacokinetic Model with Fraction Metabolized by CYP3A4.

Pin Jiang, Tao Chen, Lin-Feng Chu

|Sep 13, 2018
Correction to: Evaluation of Generic Methods to Predict Human Pharmacokinetics Using Physiologically Based Pharmacokinetic Model for Early Drug Discovery of Tyrosine Kinase Inhibitors.

Hong-Can Ren, Yang Sai, Tao Chen

|Jul 25, 2018
Evaluation of Generic Methods to Predict Human Pharmacokinetics Using Physiologically Based Pharmacokinetic Model for Early Drug Discovery of Tyrosine Kinase Inhibitors.

Hong-Can Ren, Yang Sai, Tao Chen

Pageof 1

Frequent Collaborators